03246nam 2200661Ia 450 991095329730332120260115190806.01-134-87104-X1-283-88277-91-134-87105-80-203-13289-01-280-40834-0978661040834410.4324/9780203132890(CKB)1000000000005182(SSID)ssj0000202181(PQKBManifestationID)11166829(PQKBTitleCode)TC0000202181(PQKBWorkID)10250757(PQKB)11469931(MiAaPQ)EBC178260(Au-PeEL)EBL178260(CaPaEBR)ebr5003555(CaONFJC)MIL40834(OCoLC)437250677(OCoLC)70763251(EXLCZ)99100000000000518219941216d1995 uy 0engurcn|||||||||txtccrMichael Fordham innovations in analytical psychology /James Astor1st ed.London ;New York Routledge1995viii, 271 pMakers of modern psychotherapyBibliographic Level Mode of Issuance: Monograph0-415-09348-1 0-415-09349-X Includes bibliographical references (p. [260]-263) and index.1. Thinking into feeling : the person -- 2. Jung's psychological model -- 3. Jung and Fordham -- 4. The self in infancy and childhood : pioneering discoveries -- 5. Ego development in infancy and childhood : the integration of observational research -- 6. Archetypes : their biological basis and actions of the self -- 7. Autism : a disorder of the self -- 8. The discovery of the syntonic transference, and of the importance of analysing childhood -- 9. Countertransference, interaction and not knowing beforehand -- 10. Defences of the self, projective identification and identity -- 11. Christian experience, mysticism and the self -- 12. Synchronicity : an interpretation.In the published work of Michael Fordham there has emerged a consistent and original contribution to Jungian thought, particularly in relation to the processes of individuation on childhood and the links between analytical psychology and the work of the Kleinians. In this addition to the "Makers of Modern Psychotherapy" series, the author takes a critical and informed look at Fordham's work and ideas. Illustrating theory with examples drawn from clinical practice, the book is intended to provide an amplification of Fordham's own work for students of analytical psychology and an introduction to the subject for analysts interested in understanding the connections between post-Jungian and post-Kleinian thought.Makers of modern psychotherapy.Jungian psychologyPsychotherapyJungian psychology.Psychotherapy.150.19/54/092Astor James1945-1875932MiAaPQMiAaPQMiAaPQBOOK9910953297303321Michael Fordham4487259UNINA05391nam 2200697Ia 450 991096835970332120251116192004.01-281-11191-097866111119150-08-055619-1(CKB)1000000000383521(EBL)328555(OCoLC)476125905(SSID)ssj0000121684(PQKBManifestationID)11135463(PQKBTitleCode)TC0000121684(PQKBWorkID)10111198(PQKB)10287899(MiAaPQ)EBC328555(Au-PeEL)EBL328555(CaPaEBR)ebr10204244(CaONFJC)MIL111191(PPN)182565440(EXLCZ)99100000000038352120080328d2007 uy 0engurcn|||||||||txtccrThe cholesterol wars the skeptics vs. the preponderance of evidence /Daniel Steinberg1st ed.San Diego, Calif. Academic Press20071 online resource (253 p.)Description based upon print version of record.0-12-373979-9 Includes bibliographical references and index.Front Cover; The Cholesterol Wars: The Skeptics vs. the Preponderance of Evidence; Copyright Page; Contents; Foreword; Preface; Acknowledgments; Chapter 1. Overview; On the nature of medical controversy; An overview of the cholesterol wars; Where we stand today; References; Chapter 2. Animal Models of Atherosclerosis; Nikolai N. Anitschkow and the cholesterol-fed rabbit; Why wasn't Anitschkow's lead followed up?; What led Anitschkow to feed rabbits cholesterol?; Atherosclerosis in other species; Notes; ReferencesChapter 3. Hypercholesterolemia and Atherosclerosis in Humans: Causally Related? The clinical and genetic evidence; Do more modest degrees of hypercholesterolemia, such as are found in a general population, confer risk of premature coronary heart disease?; The epidemiologic evidence; Dietary fat, blood cholesterol, and coronary heart disease; Do diets rich in saturated fats really raise blood cholesterol?; Experimental findings; Observational studies; The contribution of dietary cholesterol intake; Early clinical trials of dietary intervention; Additional pre-1970 studiesOverview of all of the pre-1970's diet intervention studies A brief wrap-up of the case against cholesterol as of 1970; Note; References; Chapter 4. Building the Basic Science Foundation; The biosynthesis of cholesterol and its metabolic regulation; The rate-limiting step, HMGCo A reductase; The birth of the lipoproteins and the John W. Gofman story; Unraveling the complex metabolism and interactions of the plasma lipoproteins; Which lipoproteins are proatherogenic?; The National Heart Institute story; Bringing the lipoprotein package concept into clinical practiceMoving from phenotype to genotypeReferences; Chapter 5. In Search of a Pathogenesis; The importance of understanding mechanism in gaining acceptance of a hypothesis; Early attempts to define the pathogenesis of atherosclerosis; The response-to-injury hypothesis and the monoclonal hypothesis; Understanding the role of HDL as an atheroprotective factor; An update on HDL as a target for intervention; Discovery of the LDL receptor: the remarkable partnership of Brown and Goldstein; Goldstein and Brown start their search for the faulty gene in familial hypercholesterolemiaDiscovery of the scavenger receptor on macrophages Oxidatively modified LDL and atherogenesis; Inflammation in the pathogenesis of atherosclerosis; Weighing the relative importance of inflammation and hyperlipidemia; Regression of atherosclerosis; Status of the lipid hypothesis in the 1980's; Note; References; Chapter 6. The Search for Cholesterol-lowering Drugs; Hypocholesterolemic drugs as a target: cons and pros Nicotinic acid; Bile acid-binding resins; Clofibrate; Probucol; Another blow: the somewhat messy Coronary Drug Project; The cholesterol controversy at its height; ReferencesChapter 7. The 1984 Coronary Primary Prevention TrialToday, in the era of the statins (cholesterol lowering drugs), there is no longer any doubt about the value of lowering blood cholesterol levels. This book chronicles the controversy that swirled around the 'lipid hypothesis' of atherosclerosis for so many years. In fact, 'the lower the better' is the position of many clinicians. However, getting to this point has been a long uphill battle marked by heated debate and sometimes violent disagreement. The history of this controversy is told here for its own sake and because remembering it may help us avoid similar mistakes in the future.AtherosclerosisAnticholesteremic agentsStatins (Cardiovascular agents)Atherosclerosis.Anticholesteremic agents.Statins (Cardiovascular agents)616.1/36616.136061616.136061Steinberg Daniel1922-2015.1890319MiAaPQMiAaPQMiAaPQBOOK9910968359703321The cholesterol wars4532121UNINA